Trademark Overview
On Monday, September 16, 2024, a trademark application was filed for POWER AHEAD ADHD HEALTH, EDUCATON & ADVOCACY DIALOGUE with the United States Patent and Trademark Office. The USPTO has given the POWER AHEAD ADHD HEALTH, EDUCATON & ADVOCACY DIALOGUE trademark a serial number of 98753172. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, September 16, 2024. This trademark is owned by Otsuka America Pharmaceutical, Inc.. The POWER AHEAD ADHD HEALTH, EDUCATON & ADVOCACY DIALOGUE trademark is filed in the Advertising, Business and Retail Services, Paper & Printed Material Products, Education & Entertainment Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Educational services, namely, conducting educational programs, seminars, presentations, and conferences in the field of attention deficit hyperactivity disorder (ADHD) and management; providing a website featuring non-downloadable information and videos about attention deficit hyperactivity disorder (ADHD) and management; providing a website featuring advocacy services and public awareness information attention deficit hyperactivity disorder (ADHD) and mental health
Downloadable software for providing information and tools in the nature of assisting patients, caregivers, and medical professionals in the field of attention deficit hyperactivity disorder (ADHD) and management; Downloadable educational media in the nature of articles, newsletters, reports, and videos attention deficit hyperactivity disorder (ADHD) and management
promoting interest and public awareness attention deficit hyperactivity disorder (ADHD); advocacy for public policies relating to attention deficit hyperactivity disorder (ADHD) and mental health; providing public policy information regarding attention deficit hyperactivity disorder (ADHD) and mental health
Providing online educational information in the field of the diagnosis, treatment, and management of attention deficit hyperactivity disorder (ADHD)